Skip to content
Directory

Treatment, Medication & Supplement Directory

A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.

Directory explains “what it is.”Guides explain how owners can discuss, use, monitor, or prepare for a treatment option with veterinary guidance.
Filtered (8)
Filtered (8)
Filter

Filter

8 directory found

Type
See more See less
Species
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
See more See less
Product Family
See more See less
Regulatory Status
See more See less
Region / Availability
See more See less
Search
Apply(8) Reset
Show (8)
Cancel
Apply(8) Reset
8 entriesShowing 1–8
Veterinarian assessing comfort and mobility with a calm dog and caregiverNamed profile Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.
Pain Medication · Supportive-care medicine · Anti-NGF monoclonal antibodies · Dogs · Long-term Management · Palliative / Comfort Care · Published Study

Bedinvetmab (Librela): Canine Osteoarthritis Pain Support in Oncology

bedinvetmab is covered as canine monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian assessing comfort and mobility with a calm dog and caregiverNamed profile Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in OncologyRepresentative category illustration – no product packaging is shown.
Pain Medication · Supportive-care medicine · Anti-NGF monoclonal antibodies · Cats · Long-term Management · Palliative / Comfort Care · Published Study

Frunevetmab (Solensia): Feline Osteoarthritis Pain Support in Oncology

frunevetmab is covered as feline monoclonal-antibody analgesic for osteoarthritis pain; not an antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing hydration and digestive symptom monitoring with a dog caregiverNamed profile Acid-Suppression Medicines in Veterinary Oncology: Rational-Use ProfileRepresentative category illustration – no product packaging is shown.
Supportive-care medicine · Gastric acid-suppression medicines · Dogs & Cats · After Surgery · During Chemotherapy · Palliative / Comfort Care · Published Study

Acid-Suppression Medicines in Veterinary Oncology: Rational-Use Profile

proton-pump inhibitors and histamine-2 receptor antagonists is covered as gastrointestinal supportive-medicine class, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinary nutrition consultation with a dog and caregiverNamed profile Cobalamin (Vitamin B12) in Canine and Feline Oncology SupportRepresentative category illustration – no product packaging is shown.
Nutrition Support · Supportive-care medicine · Cobalamin replacement · Dogs & Cats · During Chemotherapy · Long-term Management · Published Study

Cobalamin (Vitamin B12) in Canine and Feline Oncology Support

cobalamin (vitamin B12) is covered as nutrient replacement for documented or strongly suspected deficiency; not a universal cancer supplement, with species, evidence, regulatory, safety, interaction and monitoring boundaries…

Read more
Veterinarian reviewing organ protection, hydration and laboratory monitoring with a dogNamed profile Mesna in Veterinary Oncology: Uroprotection With Ifosfamide and CyclophosphamideRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Thiol uroprotectants · Dogs · During Chemotherapy · Published Study · Veterinary Clinical Use

Mesna in Veterinary Oncology: Uroprotection With Ifosfamide and Cyclophosphamide

mesna (sodium 2-mercaptoethane sulfonate) is covered as protocol-linked uroprotective medicine; not antitumour therapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing organ protection, hydration and laboratory monitoring with a dogNamed profile Dexrazoxane in Veterinary Oncology: Anthracycline Rescue and CardioprotectionRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Anthracycline protective agents · Dogs & Cats · During Chemotherapy · Limited / Emerging Evidence · Veterinary Clinical Use

Dexrazoxane in Veterinary Oncology: Anthracycline Rescue and Cardioprotection

dexrazoxane is covered as emergency extravasation antidote and selected anthracycline cardioprotectant, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.

Read more
Veterinarian reviewing organ protection, hydration and laboratory monitoring with a dogNamed profile Furosemide as a Cyclophosphamide Uroprotection Adjunct in DogsRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Cyclophosphamide bladder-protection strategies · Dogs · During Chemotherapy · Published Study · Veterinary Clinical Use

Furosemide as a Cyclophosphamide Uroprotection Adjunct in Dogs

furosemide used as a protocol adjunct is covered as loop diuretic used within selected canine cyclophosphamide protocols; not antitumour therapy, with species, evidence, regulatory, safety, interaction and monitoring…

Read more
Caregiver and veterinary professional reviewing symptom observations for a dogNamed profile H1 and H2 Blockade Around Mast-Cell Degranulation RiskRepresentative category illustration – no product packaging is shown.
Prescription Drug · Supportive-care medicine · Mast-cell mediator blockade · Dogs · During Targeted Therapy · Veterinary Clinical Use · Label-linked companion-medication context

H1 and H2 Blockade Around Mast-Cell Degranulation Risk

H1-receptor and H2-receptor blocking companion medicines is covered as protocol-linked supportive medicines; not direct antitumour treatment, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led…

Read more